Seidel-Dugan Cynthia 4
4 · Werewolf Therapeutics, Inc. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Seidel-Dugan Cynthia
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-03+115,900→ 115,900 totalExercise: $2.05Exp: 2032-12-31→ Common Stock (115,900 underlying)
Footnotes (1)
- [F1]The option was granted on January 3, 2023 with a Vesting Commencement Date of January 1, 2023. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2027.